BC
KURA icon

Bridgefront Capital’s Kura Oncology KURA Stock Holding History

Bridgefront Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,708
Closed -$108K – 709
2025
Q2 		$108K Buy
+18,708
New +$115K 0.03% 572
2022
Q2 		– Sell
-11,206
Closed -$180K – 383
2022
Q1 		$180K Buy
+11,206
New +$162K 0.22% 212
2021
Q1 		– Sell
-15,196
Closed -$496K – 807
2020
Q4 		$496K Buy
+15,196
New +$534K 0.17% 205

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Bridgefront Capital's KURA Position: Q3 2025 in Review

Bridgefront Capital sold out of Kura Oncology (KURA) in Q3 2025, closing a stake of 18,708 shares — an estimated $108K sold.

Bridgefront Capital first reported a position in KURA in Q4 2020 and held it in 3 quarters. The position peaked at $496K in Q4 2020. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Bridgefront Capital reported no remaining Kura Oncology position as of Q3 2025 after selling out during the quarter.
  • Bridgefront Capital sold 18,708 Kura Oncology shares in Q3 2025, an estimated $108K.
  • Bridgefront Capital first reported a position in Kura Oncology in Q4 2020 and held it in 3 quarters.
  • Bridgefront Capital's Kura Oncology position peaked at $496K in Q4 2020.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Bridgefront Capital's 13F filing for Q3 2025, filed 14 Nov 2025.